Inhibition of PDE5 suppresses cGMP hydrolysis, resulting in the activation of protein kinase G (PKG) and increased phosphorylation of CREB at Ser133, which rescues LTP impairment and cognitive dysfunction in an amyloid precursor protein/presenilin-1 (APP/PS1) AD mouse model [9]. Here, PDE5A is linked to Alzheimer disease.